A Study of RC148 As a Single Agent and Combination Therapy in Patients with Locally Advanced Unresectable or Metastatic Malignant Solid Tumors
A phase 1/2 trial of Docetaxel and Bevacizumab in advanced solid tumours, run by RemeGen Co., Ltd., now recruiting.
Overview
A Study of RC148 As a Single Agent and Combination Therapy in Patients with Locally Advanced Unresectable or Metastatic Malignant Solid Tumors is a phase 1/2 interventional study registered as NCT06016062 by RemeGen Co., Ltd., with 221 participants planned, started 2023-09-14 and due to reach its primary completion in 2025-12-31. Interventions recorded: RC148 Monotherapy, RC148+docetaxel Combination Therapy, RC148+RC48 Combination Therapy, RC148+RC88 Combination Therapy and RC148/Bevacizumab+RC88 Combination Therapy.
Similar pages
not linked directly; found by shared links- TrialA I/II Phase Clinical Study to Evaluate the Safety and Efficacy of RC278 in the Treatment of Solid Tumors
Shares RemeGen, Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialA Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumours[Substudy 01(NSCLC)]
Shares Docetaxel, Bevacizumab, Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialA Study of BMS-986490 With or Without Bevacizumab in Advanced Solid Tumors
Shares Bevacizumab, Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialA Study of ASKG915 in Patients With Selected Advanced Solid Tumors.
Shares Docetaxel, Bevacizumab, Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialSKB264 Monotherapy in Selected Subjects With Advanced Solid Tumors
Shares Docetaxel, Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialA Study of RC118 in Patients with Locally Advanced Unresectable or Metastatic Malignant Solid Tumors
Shares RemeGen, Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialS-531011 as Monotherapy and in Combination With an Immune Checkpoint Inhibitor in Advanced or Metastatic Solid Tumors
Shares Bevacizumab, Metastatic cancer (cancer that has spread) and the tag pipeline.
- TrialSubstudy 01I: A Study of Investigational Agents in Participants With Previously Treated Stage IV Squamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01I/KEYMAKER-U01I)
Shares Docetaxel, Metastatic cancer (cancer that has spread) and the tag pipeline.